Theodorou N A, Vrbova H, Tyhurst M, Howell S L
Diabetologia. 1980 Apr;18(4):313-7. doi: 10.1007/BF00251012.
Islets of Langerhans have been enclosed in polycarbonate diffusion chambers and transplanted intraperitoneally to syngeneic streptozotocin diabetic rats. Direct implantation of 1100--1400 islets in these chambers failed to reverse diabetes during a period of 12 weeks, and viable islet tissue was not recoverable at the end of this period. Islets placed in chambers which had been implanted 3--12 weeks previously similarly failed to lower blood glucose of diabetic recipients, as a result of lack of survival of the islets. Insulin infusion into chambers previously implanted in vivo, I125 insulin diffusion studies in chambers recovered 6--8 weeks after implantation, and scanning electron microscopy of the recovered membranes all indicated that the pores were not totally occluded. The failure of islet transplantation via chambers in this simple syngeneic model has discouraging implications for their use as a means of avoiding allograft rejection.
胰岛被包裹在聚碳酸酯扩散小室中,并腹腔内移植到同基因链脲佐菌素诱导的糖尿病大鼠体内。在这些小室中直接植入1100 - 1400个胰岛,在12周的时间内未能逆转糖尿病,且在此期间结束时无法回收存活的胰岛组织。放置在3 - 12周前已植入的小室中的胰岛同样未能降低糖尿病受体的血糖,这是由于胰岛无法存活。向先前植入体内的小室中注入胰岛素、对植入后6 - 8周回收的小室进行I125胰岛素扩散研究以及对回收膜进行扫描电子显微镜检查均表明,孔隙并未完全堵塞。在这个简单的同基因模型中,通过小室进行胰岛移植失败,这对于将其用作避免同种异体移植排斥的手段具有令人沮丧的影响。